|
Volumn 79, Issue 11, 2012, Pages 1181-1182
|
Clinical/Scientific notes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NUCLEIC ACID BINDING PROTEIN;
SPINOCEREBELLAR ATAXIA TYPE 13 PROTEIN;
UNCLASSIFIED DRUG;
VOLTAGE GATED POTASSIUM CHANNEL;
KCNC3 PROTEIN, HUMAN;
SHAW POTASSIUM CHANNEL;
ALLELE;
CLINICAL PROTOCOL;
DYSARTHRIA;
EPILEPSY;
FILIPINO;
GENE MUTATION;
GENOTYPE;
HUMAN;
IN VITRO STUDY;
MENTAL DEFICIENCY;
NOTE;
OCULOMOTOR SYSTEM;
PHENOTYPE;
PRIORITY JOURNAL;
SPINOCEREBELLAR ATAXIA TYPE 13;
SPINOCEREBELLAR DEGENERATION;
VISUAL SYSTEM;
WILD TYPE;
AGED;
ARTICLE;
CHILD;
EYE MOVEMENT;
GENETICS;
MIDDLE AGED;
AGED;
AGED, 80 AND OVER;
CHILD;
EYE MOVEMENTS;
HUMANS;
MIDDLE AGED;
PHENOTYPE;
SHAW POTASSIUM CHANNELS;
SPINOCEREBELLAR DEGENERATIONS;
|
EID: 84867504181
PISSN: 00283878
EISSN: 1526632X
Source Type: Journal
DOI: 10.1212/WNL.0b013e3182698d5c Document Type: Article |
Times cited : (5)
|
References (7)
|